{"id":1002262,"date":"2026-09-10T06:03:37","date_gmt":"2026-09-10T10:03:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/"},"modified":"2026-09-10T06:03:37","modified_gmt":"2026-09-10T10:03:37","slug":"kestra-names-daniel-finney-vice-president-of-research-development","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/","title":{"rendered":"Kestra Names Daniel Finney Vice President of Research &amp; Development"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">KIRKLAND, Wash., Sept.  10, 2026  (GLOBE NEWSWIRE) &#8212; Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research &amp; Development and appointed to the company\u2019s executive leadership team.<\/p>\n<p align=\"justify\">\u201cResearch and development is central to advancing our mission and expanding the role of wearable protection for at-risk patients during critical periods of recovery,\u201d said Brian Webster, President and Chief Executive Officer. \u201cThe Cardiac Recovery System<sup>\u00ae<\/sup> platform was designed from the outset to evolve. Dan\u2019s hands-on role in developing the ASSURE<sup>\u00ae<\/sup> WCD, together with his technical depth, product experience, and demonstrated leadership, positions him to guide our next phase of innovation and extend the platform\u2019s value for patients and providers.\u201d<\/p>\n<p align=\"justify\">Mr. Finney succeeds Phillip D. Foshee, Jr., who led Kestra\u2019s research and development organization from 2016 until his recent retirement. During his nearly decade-long tenure, Mr. Foshee spearheaded the development of the ASSURE WCD and helped establish the technical foundation on which Kestra continues to build.<\/p>\n<p align=\"justify\">The appointment comes as Kestra advances an integrated product strategy across the Cardiac Recovery System platform. Building on its extensible architecture, Mr. Finney will lead initiatives spanning internal research and development, strategic partnerships, and the application of AI, with priorities informed by clinical evidence and real-world insights from patients and clinicians. This evidence base includes findings from the ASSURE Clinical Evaluation Post-Approval Study (ACE-PAS), the largest prospective real-world study of wearable cardioverter defibrillators conducted to date.<\/p>\n<p align=\"justify\">\u201cIt has been incredibly rewarding to be part of the team that brought the ASSURE WCD from concept to market and to see firsthand its impact on patients and its role in expanding the wearable defibrillator category,\u201d said Mr. Finney. \u201cThat experience gives me confidence in the strength and potential of the Cardiac Recovery System platform. I\u2019m genuinely excited about our vision and roadmap, and I look forward to leading this team as we advance the next generation of wearable cardiac protection.\u201d<\/p>\n<p align=\"justify\">Mr. Finney has more than 20 years of experience in Class III medical device development, engineering management, and project management. Most recently, he served as Kestra\u2019s Senior Director of New Product Development, leading engineering teams and product development initiatives. Before joining Kestra, he held product development roles with Stryker, Physio-Control, and Medtronic.<\/p>\n<p align=\"justify\">\n        <strong>About Kestra<\/strong><br \/>\n        <br \/>Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MAMTbm7EqnO45HGq49E1vAshCUu1VPkPs9UGM3BWf78P8Tji89I9rQgm78ayGTmoiJTDVoE2-ebbDsA7pOCwr1IROA2If5ng6n_qaEXfRFg=\" rel=\"nofollow\" target=\"_blank\"><u>www.kestramedical.com<\/u><\/a>.\u00a0<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>Except where otherwise noted, the information contained in this press release is as of April 22, 2026. Statements in this press release that express a belief, expectation or intention, as well as those that are not historical fact, are forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Given their forward-looking nature, these statements involve substantial risks, uncertainties and potentially inaccurate assumptions, and we cannot ensure that any outcome expressed in these forward-looking statements will be realized in whole or in part. You can identify these statements by the fact that they use future dates or use words such as \u201cwill,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201clikely,\u201d \u201congoing,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cproject,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cassume,\u201d \u201ctarget,\u201d \u201cforecast,\u201d \u201cguidance,\u201d \u201cgoal,\u201d \u201cobjective,\u201d \u201caim,\u201d \u201cseek,\u201d \u201cpotential,\u201d \u201chope\u201d and other words and terms of similar meaning. Among the factors that could cause actual results to differ materially from past results and future plans and projected future results are the following: risks related to our limited operating history and history of net losses; our ability to successfully achieve substantial market adoption of our products; competitive pressures; our ability to adapt our manufacturing and production capacities to evolving patterns of demand, governmental actions and customer trends; product defects or complaints and related liability; our ability to obtain and maintain adequate coverage and reimbursement levels for our products; our ability to comply with changing laws and regulatory requirements and resulting costs; our dependence on a limited number of suppliers; and other risks and uncertainties, including those described under the heading \u201cRisk Factors\u201d in Kestra\u2019s Annual Report on Form 10-K for the fiscal year ended April 30, 2026 filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) on July 14, 2026, and in other periodic reports filed by Kestra with the SEC. These filings are available on the Investor Relations section of our website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pHQBXiWzueY1yToA17_0Nh4YbHd_ApPYMgmDNFggSiLp9KvYdHcAG48Uirr8Sl8bA7jq7x0PrEYDgkqU50TztYYfZ_FZS7D-0BOhX7Yg8tbbSilFEiYyjGYVK62GGymiGATqjxFLeIz2DAB8dc8dVQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.kestramedical.com\/<\/a> and on the SEC\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pHQBXiWzueY1yToA17_0NkWocTGxcR24Hn-8Z65TsSD3OmuezE2VGnXD-DlJB8rr8T-g2hC3b8GlxM2UZcJ3rA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/sec.gov\/<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODA3ZGUzNzgtZTgzNi00YWNlLTk2NzctZjU0YzY5YTBhODVjLTEzMDk2MTUtMjAyNi0wOS0xMC1lbg==\/tiny\/Kestra-Medical-Technologies-Lt.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Media contact\u00a0\r\nRhiannon Pickus\u00a0\r\nrhiannon.pickus@kestramedical.com\u00a0\r\n\r\nInvestor contact\u00a0\r\nNeil Bhalodkar\u00a0\r\nneil.bhalodkar@kestramedical.com\u00a0<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) &#8212; Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research &amp; Development and appointed to the company\u2019s executive leadership team. \u201cResearch and development is central to advancing our mission and expanding the role of wearable protection for at-risk patients during critical periods of recovery,\u201d said Brian Webster, President and Chief Executive Officer. \u201cThe Cardiac Recovery System\u00ae platform was designed from the outset to evolve. Dan\u2019s hands-on role in developing the ASSURE\u00ae WCD, together with his technical depth, product experience, and demonstrated leadership, positions him to guide our next phase of innovation and extend the platform\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kestra Names Daniel Finney Vice President of Research &amp; Development&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1002262","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kestra Names Daniel Finney Vice President of Research &amp; Development - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kestra Names Daniel Finney Vice President of Research &amp; Development - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) &#8212; Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research &amp; Development and appointed to the company\u2019s executive leadership team. \u201cResearch and development is central to advancing our mission and expanding the role of wearable protection for at-risk patients during critical periods of recovery,\u201d said Brian Webster, President and Chief Executive Officer. \u201cThe Cardiac Recovery System\u00ae platform was designed from the outset to evolve. Dan\u2019s hands-on role in developing the ASSURE\u00ae WCD, together with his technical depth, product experience, and demonstrated leadership, positions him to guide our next phase of innovation and extend the platform\u2019s &hellip; Continue reading &quot;Kestra Names Daniel Finney Vice President of Research &amp; Development&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-10T10:03:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kestra Names Daniel Finney Vice President of Research &amp; Development\",\"datePublished\":\"2026-09-10T10:03:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/\"},\"wordCount\":790,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/\",\"name\":\"Kestra Names Daniel Finney Vice President of Research &amp; Development - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=\",\"datePublished\":\"2026-09-10T10:03:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kestra-names-daniel-finney-vice-president-of-research-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kestra Names Daniel Finney Vice President of Research &amp; Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kestra Names Daniel Finney Vice President of Research &amp; Development - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/","og_locale":"en_US","og_type":"article","og_title":"Kestra Names Daniel Finney Vice President of Research &amp; Development - Market Newsdesk","og_description":"KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) &#8212; Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research &amp; Development and appointed to the company\u2019s executive leadership team. \u201cResearch and development is central to advancing our mission and expanding the role of wearable protection for at-risk patients during critical periods of recovery,\u201d said Brian Webster, President and Chief Executive Officer. \u201cThe Cardiac Recovery System\u00ae platform was designed from the outset to evolve. Dan\u2019s hands-on role in developing the ASSURE\u00ae WCD, together with his technical depth, product experience, and demonstrated leadership, positions him to guide our next phase of innovation and extend the platform\u2019s &hellip; Continue reading \"Kestra Names Daniel Finney Vice President of Research &amp; Development\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-10T10:03:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kestra Names Daniel Finney Vice President of Research &amp; Development","datePublished":"2026-09-10T10:03:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/"},"wordCount":790,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/","name":"Kestra Names Daniel Finney Vice President of Research &amp; Development - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=","datePublished":"2026-09-10T10:03:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMzkyNyM3ODI1MzQ3IzIyOTgwNjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kestra-names-daniel-finney-vice-president-of-research-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kestra Names Daniel Finney Vice President of Research &amp; Development"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1002262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1002262"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1002262\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1002262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1002262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1002262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}